Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Hudson |
RCV000224979 | SCV000281762 | pathogenic | Charcot-Marie-Tooth disease axonal type 2X | 2016-04-14 | criteria provided, single submitter | research | |
Gene |
RCV000498920 | SCV000589883 | likely pathogenic | not provided | 2024-10-24 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 27217339, 28554332) |
Labcorp Genetics |
RCV000706352 | SCV000835396 | pathogenic | Hereditary spastic paraplegia 11 | 2023-08-16 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt SPG11 protein function. ClinVar contains an entry for this variant (Variation ID: 235890). This missense change has been observed in individual(s) with clinical features of hereditary spastic paraplegia (PMID: 27217339, 28554332; Invitae). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces leucine, which is neutral and non-polar, with proline, which is neutral and non-polar, at codon 2300 of the SPG11 protein (p.Leu2300Pro). |
Genome- |
RCV000224979 | SCV002763643 | likely pathogenic | Charcot-Marie-Tooth disease axonal type 2X | criteria provided, single submitter | clinical testing | ||
Genome- |
RCV000706352 | SCV002763644 | likely pathogenic | Hereditary spastic paraplegia 11 | criteria provided, single submitter | clinical testing |